From Staff Reports Copyright © 2015 The Oklahoma Publishing Co. i2E Inc. and Accele Venture Partners recently closed a $600,000 follow-on investment in Synereca Pharmaceuticals, a portfolio company of Accele Biopharma, an Oklahoma City-based biotechnology accelerator. With the most recent investment, Synereca has now received $2.5 million in funding to support its development of compoundsRead more